Successful treatment of Cryptococcus laurentii peritonitis in a patient on peritoneal dialysis

Intern Med. 2015;54(8):941-4. doi: 10.2169/internalmedicine.54.3586. Epub 2015 Apr 15.

Abstract

A 32-year-old man on peritoneal dialysis (PD) was hospitalized for seven days due to fever. A diagnosis of yeast-like fungal peritonitis was made by Gram staining. The patient was started on intravenous micafungin and oral fluconazole therapy following removal of the PD catheter. A fungal pathogen was isolated from the peritoneal fluid and identified as Cryptococcus species. Based on antifungal susceptibility testing, the treatment was changed to voriconazole and continued for 3 months. A genetic analysis identified the isolate as Cryptococcus laurentii (C. laurentii). This patient was diagnosed with C. laurentii PD-related peritonitis and was successfully treated with voriconazole and removal of the PD catheter.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antifungal Agents / administration & dosage*
  • Catheterization
  • Catheters, Indwelling / adverse effects
  • Catheters, Indwelling / microbiology
  • Cryptococcus / isolation & purification*
  • Device Removal
  • Echinocandins / administration & dosage*
  • Fluconazole / administration & dosage*
  • Humans
  • Lipopeptides / administration & dosage*
  • Male
  • Micafungin
  • Mycoses / drug therapy
  • Mycoses / etiology*
  • Mycoses / microbiology
  • Peritoneal Dialysis / adverse effects*
  • Peritonitis / drug therapy
  • Peritonitis / etiology*
  • Peritonitis / microbiology

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Fluconazole
  • Micafungin